Craniosynostosis–anal anomalies–porokeratosis syndrome
(Redirected from CAP syndrome)
Craniosynostosis–anal anomalies–porokeratosis syndrome is a rare genetic disorder characterized by the premature fusion of certain skull bones (craniosynostosis), anal anomalies, and porokeratosis. This condition is also known as CAP syndrome.
Etymology[edit | edit source]
The term Craniosynostosis–anal anomalies–porokeratosis syndrome is derived from the three main features of the condition: craniosynostosis, anal anomalies, and porokeratosis. The term "craniosynostosis" comes from the Greek words "krani" meaning skull, "syn" meaning together, and "ostosis" meaning condition of the bone. The term "anal anomalies" refers to abnormalities in the structure or function of the anus. The term "porokeratosis" is derived from the Greek words "poros" meaning passage, "kera" meaning horn, and "osis" meaning condition.
Symptoms[edit | edit source]
The symptoms of Craniosynostosis–anal anomalies–porokeratosis syndrome can vary greatly among individuals. The most common symptoms include:
- Premature fusion of the skull bones (craniosynostosis)
- Anal anomalies such as imperforate anus
- Skin abnormalities (porokeratosis)
Other symptoms may include facial asymmetry, hearing loss, and developmental delay.
Causes[edit | edit source]
Craniosynostosis–anal anomalies–porokeratosis syndrome is caused by mutations in the SLC25A24 gene. This gene provides instructions for making a protein that is found in the mitochondria, the energy-producing centers of cells. The exact function of this protein is not fully understood, but it is thought to play a role in the transport of certain molecules across the mitochondrial membrane.
Diagnosis[edit | edit source]
The diagnosis of Craniosynostosis–anal anomalies–porokeratosis syndrome is based on a clinical examination and confirmed by genetic testing. The genetic test involves sequencing the SLC25A24 gene to look for mutations.
Treatment[edit | edit source]
There is currently no cure for Craniosynostosis–anal anomalies–porokeratosis syndrome. Treatment is symptomatic and supportive, and may include surgery to correct craniosynostosis and anal anomalies, as well as skin treatments for porokeratosis.
See also[edit | edit source]
Craniosynostosis–anal anomalies–porokeratosis syndrome Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD